about
Functional effects of KCNE3 mutation and its role in the development of Brugada syndromeThe genetic basis of Brugada syndrome: a mutation updateThe role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygoteLong QT syndrome patients may faint due to neurocardiogenic syncope.High-efficiency multiplex capillary electrophoresis single strand conformation polymorphism (multi-CE-SSCP) mutation screening of SCN5A: a rapid genetic approach to cardiac arrhythmia.T(peak)T(end) interval in long QT syndrome.[Short QT syndrome as an inherited condition].Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.Assessing QT interval prolongation and its associated risks with antipsychotics.In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.Normal electrocardiographic QT interval in race-fit Standardbred horses at rest and its rate dependence during exercise.Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.Tilt-table testing of patients with pacemaker and recurrent syncopeMicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndromeThe phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia.Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population.Reference values of electrocardiogram repolarization variables in a healthy population.QT dynamics during treatment with sertindoleThe role of local voltage potentials in outflow tract ectopyPrivate mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach.Eosinophilic myocarditis during treatment with olanzapine - report of two possible casesAppropriate threshold levels of cardiac beat-to-beat variation in semi-automatic analysis of equine ECG recordings.Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?Left Ventricular Function After Prolonged Exercise in Equine Endurance Athletes.MT-CYB mutations in hypertrophic cardiomyopathy.Hidradenitis Suppurativa and electrocardiographic changes - a cross-sectional population study.Major stroke in a 19-year-old patient with a univentricular heart.Differences in the electrocardiographic QT interval of various breeds of athletic horses during rest and exercise.Changes in heart rate, arrhythmia frequency, and cardiac biomarker values in horses during recovery after a long-distance endurance ride.Increased iron stores prolong the QT interval - a general population study including 20 261 individuals and meta-analysis of thalassaemia major.Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia.Massive electrical storm at disease onset in a patient with Brugada syndrome.Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.Quantitative analysis of T-wave morphology increases confidence in drug-induced cardiac repolarization abnormalities: evidence from the investigational IKr inhibitor Lu 35-138.Is it possible to predict hypotension during onset of spinal anesthesia in elderly patients?Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.MT-CYB mutations in hypertrophic cardiomyopathy.Spontaneous high frequency diameter oscillations of larger retinal arterioles are reduced in type 2 diabetes mellitus.
P50
Q24655604-82B54605-0CDB-4CF0-B966-384F27A187EEQ28252115-45AF03EB-77F3-4851-B908-3FA368244CFCQ28298218-A8CA7ED6-36C8-4EE4-A9B0-662C879F2823Q33150960-55F3F866-626A-4259-A466-7672784E7414Q33153857-B4D4BC0C-0DAA-4EC3-A5F8-8ED9E9E7C5E5Q33156651-7D7738B2-B296-47B4-A771-1510644DF5E3Q33159697-50AA284C-2139-4107-875C-3AF9D13E31CBQ33159880-00DC01D4-B83F-4F84-A79B-26BD0D6422ACQ33160123-801A1581-08F6-4A86-A4C2-B428C0428675Q33162028-086AF929-8997-4E83-B6FB-4E17A2A6FA72Q33162409-E2FD8A7A-4B0B-4E77-B235-0A142B2512F6Q33166274-098D28D3-BEE9-417D-B7F5-741B8D0CE26EQ33166885-39822367-B697-4F04-AA14-C261F147FCBCQ34336568-6CBF5208-DE6D-4D24-9042-090D9DD44ACDQ34358846-AA05F75A-98B1-4342-84D3-ACA331FE691DQ34393350-6FABC73A-5382-4F5E-A364-3169FF8C635AQ34938120-CD021882-3D79-41AA-8B59-28CDAA7398E8Q35001833-37C7298E-AB8E-4542-A05D-E96A6562ED52Q35044184-56EE6715-9D0A-401B-A25B-E0A7A50676F3Q35452490-0FF2C134-B94E-4250-9F04-850F3B891E71Q35552917-379CDE09-98DA-4530-9884-09882E442D19Q35731977-07AF048E-F353-4008-A3B4-8038EA6057D2Q35961895-EE86E96A-CF8F-439C-A76C-845A5A3C1F01Q36206005-1162AFE6-62FA-40DF-B93C-59E3391B2FDFQ36571485-0B87B789-D82A-495B-9C9A-37C766D0A779Q37391746-8EAB2F9E-7202-4B40-8A9B-E3C029FF0558Q37483898-2E35FE85-7AD6-4C16-872D-F75E410A393DQ38698982-A8580F39-DD8C-49C3-994C-A92456355C60Q39479893-34668412-F69A-490A-8C25-75E88E6ECB82Q39858720-3C063F0E-AC9D-415C-A335-57BDA29BA773Q40802778-DDF72677-E974-4A52-8CD6-2C2BD24F8F5AQ40808732-C2372194-26A5-45E9-A31C-F22BC54DF737Q41590303-8A72713B-ED15-46EB-8EC8-9B01B812EEA3Q41930815-4A4E3C59-5D6A-4DE8-A71B-4E7C7CEAACCAQ43059195-35318F71-A53D-422F-9F19-8D2BDEA04FFBQ43258117-B16B994E-BD37-4F28-BB81-60633D3A466FQ43806815-B33F04EF-A3F5-4D51-AD1C-8F58E7839607Q45967391-45AD9C7A-0308-4E3D-9A75-74CEAF3DED70Q46589649-C8935F95-0CF7-4527-8A30-327173340DB5Q46601619-D317D7DF-5A46-48FF-A1ED-2441A03DD115
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jorgen K Kanters
@nl
Jorgen K Kanters
@sl
Jorgen K. Kanters
@en
Jorgen K. Kanters
@es
type
label
Jorgen K Kanters
@nl
Jorgen K Kanters
@sl
Jorgen K. Kanters
@en
Jorgen K. Kanters
@es
altLabel
JK Kanters
@en
prefLabel
Jorgen K Kanters
@nl
Jorgen K Kanters
@sl
Jorgen K. Kanters
@en
Jorgen K. Kanters
@es
P106
P1153
7006830308
P31
P496
0000-0002-3267-4910